<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05910000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P13726</UniProt_ID>
  <Seq_Length>295</Seq_Length>
  <Molecule_Weight>33068</Molecule_Weight>
  <KEGG_ID>hsa:2152</KEGG_ID>
  <Orthology_ID>K03901</Orthology_ID>
  <Function_Summary>Initiates blood coagulation by forming a complex with circulating factor VII or VIIa. The [TF:VIIa] complex activates factors IX or X by specific limited protolysis. TF plays a role in normal hemostasis by initiating the cell-surface assembly and propagation of the coagulation protease cascade.</Function_Summary>
  <Pfam_ID>PF09294:Interfer-bind</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>TF</Alias>
      <Alias>Coagulation factor III</Alias>
      <Alias>Thromboplastin</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protease or peptidase.</Detail>
      <Keyword>Protease binding</Keyword>
      <Ontology_ID>GO:0002020</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.</Detail>
      <Keyword>Phospholipid binding</Keyword>
      <Ontology_ID>GO:0005543</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any component on the surface of a cell.</Detail>
      <Keyword>Cell surface binding</Keyword>
      <Ontology_ID>GO:0043498</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>163</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.</Detail>
      <Keyword>Hemostasis</Keyword>
      <Ontology_ID>GO:0007599</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.</Detail>
      <Keyword>Positive regulation of positive chemotaxis</Keyword>
      <Ontology_ID>GO:0050927</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process which directly inhibits any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Anti-apoptosis</Keyword>
      <Ontology_ID>GO:0006916</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway.</Detail>
      <Keyword>Positive regulation of platelet-derived growth factor receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0010641</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process activating plasma proteins by proteolysis as part of an acute inflammatory response.</Detail>
      <Keyword>Activation of plasma proteins involved in acute inflammatory response</Keyword>
      <Ontology_ID>GO:0002541</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.</Detail>
      <Keyword>Blood coagulation, extrinsic pathway</Keyword>
      <Ontology_ID>GO:0007598</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that initiates the clotting cascade of blood coagulation, a cascade of plasma enzymes that is triggered following damage to blood vessels, leading to formation of a clot.</Detail>
      <Keyword>Activation of blood coagulation via clotting cascade</Keyword>
      <Ontology_ID>GO:0002543</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of endothelial cell proliferation.</Detail>
      <Keyword>Positive regulation of endothelial cell proliferation</Keyword>
      <Ontology_ID>GO:0001938</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases angiogenesis.</Detail>
      <Keyword>Positive regulation of angiogenesis</Keyword>
      <Ontology_ID>GO:0045766</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the protein kinase B signaling cascade, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.</Detail>
      <Keyword>Positive regulation of protein kinase B signaling cascade</Keyword>
      <Ontology_ID>GO:0051897</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Upregulation of the activity of a caspase, any of a group of cysteine proteases involved in apoptosis.</Detail>
      <Keyword>Activation of caspase activity</Keyword>
      <Ontology_ID>GO:0006919</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>METPAWPRVPRPETAVARTLLLGWVFAQVAGASGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECMGQEKGEFREIFYIIGAVVFVVIILVIILAISLHKCRKAGVGQSWKENSPLNVS</Protein_Seq>
    <DNA_Seq>GGAGTCGGGAGGAGCGGCGGGGGCGGGCGCCGGGGGCGGGCAGAGGCGCGGGAGAGCGCGCCGCCGGCCCTTTATAGCGCGCGGGGCACCGGCTCCCCAAGACTGCGAGCTCCCCGCACCCCCTCGCACTCCCTCTGGCCGGCCCAGGGCGCCTTCAGCCCAACCTCCCCAGCCCCACGGGCGCCACGGAACCCGCTCGATCTCGCCGCCAACTGGTAGACATGGAGACCCCTGCCTGGCCCCGGGTCCCGCGCCCCGAGACCGCCGTCGCTCGGACGCTCCTGCTCGGCTGGGTCTTCGCCCAGGTGGCCGGCGCTTCAGGCACTACAAATACTGTGGCAGCATATAATTTAACTTGGAAATCAACTAATTTCAAGACAATTTTGGAGTGGGAACCCAAACCCGTCAATCAAGTCTACACTGTTCAAATAAGCACTAAGTCAGGAGATTGGAAAAGCAAATGCTTTTACACAACAGACACAGAGTGTGACCTCACCGACGAGATTGTGAAGGATGTGAAGCAGACGTACTTGGCACGGGTCTTCTCCTACCCGGCAGGGAATGTGGAGAGCACCGGTTCTGCTGGGGAGCCTCTGTATGAGAACTCCCCAGAGTTCACACCTTACCTGGAGACAAACCTCGGACAGCCAACAATTCAGAGTTTTGAACAGGTGGGAACAAAAGTGAATGTGACCGTAGAAGATGAACGGACTTTAGTCAGAAGGAACAACACTTTCCTAAGCCTCCGGGATGTTTTTGGCAAGGACTTAATTTATACACTTTATTATTGGAAATCTTCAAGTTCAGGAAAGAAATATTCTACATCATTGGAGCTGTGGTATTTGTGGTCATCATCCTTGTCATCATCCTGGCTATATCTCTACACAAGTGTAGAAAGGCAGGAGTGGGGCAGAGCTGGAAGGAGAACTCCCCACTGAATGTTTCATAAAGGAAGCACTGTTGGAGCTACTGCAAATGCTATATTGCACTGTGACCGAGAACTTTTAAGAGGATAGAATACATGGAAACGCAAATGAGTATTTCGGAGCATGAAGACCCTGGAGTTCAAAAAACTCTTGATATGACCTGTTATTACCATTAGCATTCTGGTTTTGACATCAGCATTAGTCACTTTGAAATGTAACGAATGGTACTACAACCAATTCCAAGTTTTAATTTTTAACACCATGGCACCTTTTGCACATAACATGCTTTAGATTATATATTCCGCACTCAAGGAGTAACCAGGTCGTCCAAGCAAAAACAAATGGGAAAATGTCTTAAAAAATCCTGGGTGGACTTTTGAAAAGCTTTTTTTTTTTTTTTTTTTTTTTTGAGACGGAGTCTTGCTCTGTTGCCCAGGCTGGAGTGCAGTAGCACGATCTCGGCTCACTGCACCCTCCGTCTCTCGGGTTCAAGCAATTGTCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGTGCGCACTACCACGCCAAGCTAATTTTTGTATTTTTTAGTAGAGATGGGGTTTCACCATCTTGGCCAGGCTGGTCTTGAATTCCTGACCTCAGGTGATCCACCCACCTTGGCCTCCCAAAGTGCTAGTATTATGGGCGTGAACCACCATGCCCAGCCGAAAAGCTTTTGAGGGGCTGACTTCAATCCATGTAGGAAAGTAAAATGGAAGGAAATTGGGTGCATTTCTAGGACTTTTCTAACATATGTCTATAATATAGTGTTTAGGTTCTTTTTTTTTTCAGGAATACATTTGGAAATTCAAAACAATTGGCAAACTTTGTATTAATGTGTTAAGTGCAGGAGACATTGGTATTCTGGGCACCTTCCTAATATGCTTTACAATCTGCACTTTAACTGACTTAAGTGGCATTAAACATTTGAGAGCTAACTATATTTTTATAAGACTACTATACAAACTACAGAGTTTATGATTTAAGGTACTTAAAGCTTCTATGGTTGACATTGTATATATAATTTTTTAAAAAGGTTTTCTATATGGGGATTTTCTATTTATGTAGGTAATATTGTTCTATTTGTATATATTGAGATAATTTATTTAATATACTTTAAATAAAGGTGACTGGGAATTGTTACTGTTGTACTTATTCTATCTTCCATTTATTATTTATGTACAATTTGGTGTTTGTATTAGCTCTACTACAGTAAATGACTGTAAAATTGTCAGTGGCTTACAACAACGTATCTTTTTCGCTTATAATACATTTTGGTGACT</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular matrix</CellLocal>
      <Ontology_ID>GO:0031012</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Intrinsic to external side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0031233</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>F3</Gene_Name>
    <Gene_ID>2152</Gene_ID>
    <Genbank_ACCN>NM_001178096</Genbank_ACCN>
    <Protein_ACCN>NP_001171567</Protein_ACCN>
    <HGNC_ID>3541</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2152</Gene_URL>
    <UCSC_ID>uc001dqr.3</UCSC_ID>
    <EMBL_ID>ENSG00000117525</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Cerebral Sinovenous Thrombosis</Disease_Name>
      <Disease_Detail>Cerebral Sinovenous Thrombosis</Disease_Detail>
      <Disease_DB>CRB132</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebral_sinovenous_thrombosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mild Hemophilia B</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>MLD014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mild_hemophilia_b?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Peripheral Vertigo</Disease_Name>
      <Disease_Detail>Peripheral Vertigo</Disease_Detail>
      <Disease_DB>PRP028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/peripheral_vertigo?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Fatty Liver of Pregnancy</Disease_Name>
      <Disease_Detail>Acute Fatty Liver of Pregnancy</Disease_Detail>
      <Disease_DB>ACT099</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_fatty_liver_of_pregnancy?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Catastrophic Antiphospholipid Syndrome</Disease_Name>
      <Disease_Detail>Catastrophic Antiphospholipid Syndrome</Disease_Detail>
      <Disease_DB>CTS005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/catastrophic_antiphospholipid_syndrome?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multifocal Lymphangioendotheliomatosis with Thrombocytopenia</Disease_Name>
      <Disease_Detail>Multifocal Lymphangioendotheliomatosis with Thrombocytopenia</Disease_Detail>
      <Disease_DB>MLT037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multifocal_lymphangioendotheliomatosis_with_thrombocytopenia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Peripheral Vascular Disease</Disease_Name>
      <Disease_Detail>Peripheral Vascular Disease</Disease_Detail>
      <Disease_DB>PRP027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/peripheral_vascular_disease?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombophlebitis</Disease_Name>
      <Disease_Detail>Thrombophlebitis</Disease_Detail>
      <Disease_DB>THR016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombophlebitis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acquired Von Willebrand Syndrome</Disease_Name>
      <Disease_Detail>Acquired Von Willebrand Syndrome</Disease_Detail>
      <Disease_DB>ACQ017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acquired_von_willebrand_syndrome?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nodular Regenerative Hyperplasia</Disease_Name>
      <Disease_Detail>Nodular Regenerative Hyperplasia</Disease_Detail>
      <Disease_DB>NDL013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nodular_regenerative_hyperplasia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemorrhagic Fever</Disease_Name>
      <Disease_Detail>Hemorrhagic Fever</Disease_Detail>
      <Disease_DB>HMR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemorrhagic_fever?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Abdominal Aortic Aneurysm</Disease_Name>
      <Disease_Detail>Abdominal Aortic Aneurysm</Disease_Detail>
      <Disease_DB>ABD003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/abdominal_aortic_aneurysm?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Scrub Typhus</Disease_Name>
      <Disease_Detail>Scrub Typhus</Disease_Detail>
      <Disease_DB>SCR008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/scrub_typhus?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dysphagia</Disease_Name>
      <Disease_Detail>Dysphagia</Disease_Detail>
      <Disease_DB>DYS073</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dysphagia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Carotid Artery Thrombosis</Disease_Name>
      <Disease_Detail>Carotid Artery Thrombosis</Disease_Detail>
      <Disease_DB>CRT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/carotid_artery_thrombosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Disseminated Intravascular Coagulation</Disease_Name>
      <Disease_Detail>Disseminated Intravascular Coagulation</Disease_Detail>
      <Disease_DB>DSS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/disseminated_intravascular_coagulation?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xiii Deficiency</Disease_Name>
      <Disease_Detail>Factor Xiii Deficiency</Disease_Detail>
      <Disease_DB>FCT005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xiii_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hantavirus Pulmonary Syndrome</Disease_Name>
      <Disease_Detail>Hantavirus Pulmonary Syndrome</Disease_Detail>
      <Disease_DB>HNT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hantavirus_pulmonary_syndrome?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphoplasmacytic Lymphoma</Disease_Name>
      <Disease_Detail>Lymphoplasmacytic Lymphoma</Disease_Detail>
      <Disease_DB>LYM012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphoplasmacytic_lymphoma?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ischemic Colitis</Disease_Name>
      <Disease_Detail>Ischemic Colitis</Disease_Detail>
      <Disease_DB>ISC015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ischemic_colitis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Hemophilia a</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>SVR056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_hemophilia_a?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sagittal Sinus Thrombosis</Disease_Name>
      <Disease_Detail>Sagittal Sinus Thrombosis</Disease_Detail>
      <Disease_DB>SGT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sagittal_sinus_thrombosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemarthrosis</Disease_Name>
      <Disease_Detail>Hemarthrosis</Disease_Detail>
      <Disease_DB>HMR002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemarthrosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thromboembolism</Disease_Name>
      <Disease_Detail>Thromboembolism</Disease_Detail>
      <Disease_DB>THR079</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thromboembolism?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Afibrinogenemia</Disease_Name>
      <Disease_Detail>Congenital Afibrinogenemia</Disease_Detail>
      <Disease_DB>CNG019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_afibrinogenemia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Von Willebrand's Disease</Disease_Name>
      <Disease_Detail>Von Willebrand's Disease</Disease_Detail>
      <Disease_DB>VNW001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/von_willebrands_disease?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glanzmann's Thrombasthenia</Disease_Name>
      <Disease_Detail>Glanzmann's Thrombasthenia</Disease_Detail>
      <Disease_DB>GLN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glanzmanns_thrombasthenia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Protein S Deficiency</Disease_Name>
      <Disease_Detail>Protein S Deficiency</Disease_Detail>
      <Disease_DB>PRT014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/protein_s_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acquired Hemophilia</Disease_Name>
      <Disease_Detail>Acquired Hemophilia</Disease_Detail>
      <Disease_DB>ACQ014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acquired_hemophilia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rosai-Dorfman Disease</Disease_Name>
      <Disease_Detail>Rosai-Dorfman Disease</Disease_Detail>
      <Disease_DB>RSD004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rosai_dorfman_disease?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xii Deficiency</Disease_Name>
      <Disease_Detail>Factor Xii Deficiency</Disease_Detail>
      <Disease_DB>FCT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xii_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor V Deficiency</Disease_Name>
      <Disease_Detail>Factor V Deficiency</Disease_Detail>
      <Disease_DB>FCT006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_v_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Vii Deficiency</Disease_Name>
      <Disease_Detail>Factor Vii Deficiency</Disease_Detail>
      <Disease_DB>FCT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_vii_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Myocardial Infarction</Disease_Name>
      <Disease_Detail>Acute Myocardial Infarction</Disease_Detail>
      <Disease_DB>ACT075</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_myocardial_infarction?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xi Deficiency</Disease_Name>
      <Disease_Detail>Factor Xi Deficiency</Disease_Detail>
      <Disease_DB>FCT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xi_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Viii Deficiency</Disease_Name>
      <Disease_Detail>Factor Viii Deficiency</Disease_Detail>
      <Disease_DB>FCT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_viii_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cryptococcosis</Disease_Name>
      <Disease_Detail>Cryptococcosis</Disease_Detail>
      <Disease_DB>CRY005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cryptococcosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilia B</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>HMP004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilia_b?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Venous Thrombosis</Disease_Name>
      <Disease_Detail>Venous Thrombosis</Disease_Detail>
      <Disease_DB>VNS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thrombosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cortical Blindness</Disease_Name>
      <Disease_Detail>Cortical Blindness</Disease_Detail>
      <Disease_DB>CRT012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cortical_blindness?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heparin-Induced Thrombocytopenia</Disease_Name>
      <Disease_Detail>Heparin-Induced Thrombocytopenia</Disease_Detail>
      <Disease_DB>HPR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heparin_induced_thrombocytopenia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Thrombosis</Disease_Name>
      <Disease_Detail>Coronary Thrombosis</Disease_Detail>
      <Disease_DB>CRN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_thrombosis?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Crimean-Congo Hemorrhagic Fever</Disease_Name>
      <Disease_Detail>Crimean-Congo Hemorrhagic Fever</Disease_Detail>
      <Disease_DB>CRM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/crimean_congo_hemorrhagic_fever?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Biphenotypic Leukemia</Disease_Name>
      <Disease_Detail>Acute Biphenotypic Leukemia</Disease_Detail>
      <Disease_DB>ACT095</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_biphenotypic_leukemia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tetrology of Fallot</Disease_Name>
      <Disease_Detail>Tetrology of Fallot</Disease_Detail>
      <Disease_DB>TTR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tetrology_of_fallot?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Venous Thromboembolism</Disease_Name>
      <Disease_Detail>Venous Thromboembolism</Disease_Detail>
      <Disease_DB>VNS010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thromboembolism?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor X Deficiency</Disease_Name>
      <Disease_Detail>Factor X Deficiency</Disease_Detail>
      <Disease_DB>FCT003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_x_deficiency?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Promyelocytic Leukemia</Disease_Name>
      <Disease_Detail>Acute Promyelocytic Leukemia</Disease_Detail>
      <Disease_DB>ACT119</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_promyelocytic_leukemia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Afibrinogenemia</Disease_Name>
      <Disease_Detail>Afibrinogenemia</Disease_Detail>
      <Disease_DB>AFB001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/afibrinogenemia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vitamin K Deficiency Hemorrhagic Disease</Disease_Name>
      <Disease_Detail>Vitamin K Deficiency Hemorrhagic Disease</Disease_Detail>
      <Disease_DB>VTM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vitamin_k_deficiency_hemorrhagic_disease?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tyrosinemia</Disease_Name>
      <Disease_Detail>Tyrosinemia</Disease_Detail>
      <Disease_DB>TYR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tyrosinemia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemophilia</Disease_Name>
      <Disease_Detail>Hemophilia</Disease_Detail>
      <Disease_DB>HMP007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemophilia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Angiodysplasia</Disease_Name>
      <Disease_Detail>Angiodysplasia</Disease_Detail>
      <Disease_DB>ANG011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/angiodysplasia?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Antiphospholipid Syndrome</Disease_Name>
      <Disease_Detail>Antiphospholipid Syndrome</Disease_Detail>
      <Disease_DB>ANT006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/antiphospholipid_syndrome?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Purpura</Disease_Name>
      <Disease_Detail>Purpura</Disease_Detail>
      <Disease_DB>PRP030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/purpura?search=F3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonary Embolism</Disease_Name>
      <Disease_Detail>Pulmonary Embolism</Disease_Detail>
      <Disease_DB>PLM033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonary_embolism?search=F3#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT</PDB_Title>
      <PDB_ID>1FAK</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FAK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.</PubMed_Title>
      <Author>Zhang, E., et al.</Author>
      <Journal>J.Mol.Biol.(1999)285:2089-2104</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9925787?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor</PDB_Title>
      <PDB_ID>1DAN</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DAN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.</PubMed_Title>
      <Author>Banner, D.W., et al.</Author>
      <Journal>Nature(1996)380:41-46</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8598903?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala190 Protease (Ala190 uPA)</PDB_Title>
      <PDB_ID>1O5D</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1O5D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).</PubMed_Title>
      <Author>Katz, B.A., et al.</Author>
      <Journal>J.Mol.Biol.(2004)344:527-547</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15522303?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of DFPR-VIIa/sTF</PDB_Title>
      <PDB_ID>2FIR</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FIR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor: Unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in factor VIIa</PubMed_Title>
      <Author>Bajaj, S.P., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:24873-24888</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16757484?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TF7A_4380 COMPLEX</PDB_Title>
      <PDB_ID>1W2K</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1W2K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design of Selective Phenylglycine Amide Tissue Factor/Factor Viia Inhibitors</PubMed_Title>
      <Author>Groebke-Zbinden, K., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2005)15:817</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15664864?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and Efficacy in a Baboon Thrombosis Model</PDB_Title>
      <PDB_ID>2B7D</PDB_ID>
      <Resolution>2.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2B7D</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.</PubMed_Title>
      <Author>Young, W.B., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:2037-2041</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16412633?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PHOSPHORYLATION OF THE CYTOPLASMIC TAIL OF TISSUE FACTOR AND ITS ROLE IN MODULATING STRUCTURE AND BINDING AFFINITY</PDB_Title>
      <PDB_ID>2CEF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CEF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and Binding Affinity</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human factor viia-tissue factor complexed with highly selective peptide inhibitor</PDB_Title>
      <PDB_ID>2ZWL</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZWL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human factor viia-tissue factor complexed with highly selective peptide inhibitor</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of tissue factor in complex with humanized Fab D3h44</PDB_Title>
      <PDB_ID>1JPS</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JPS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.</PubMed_Title>
      <Author>Faelber, K., et al.</Author>
      <Journal>J.Mol.Biol.(2001)313:83-97</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11601848?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PHOSPHORYLATION OF THE CYTOPLASMIC TAIL OF TISSUE FACTOR AND ITS ROLE IN MODULATING STRUCTURE AND BINDING AFFINITY</PDB_Title>
      <PDB_ID>2CEZ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CEZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and Binding Affinity</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor Viia-Tissue Factor in Complex with peprid mimetic inhibitor that has two charge groups in P2 and P4</PDB_Title>
      <PDB_ID>1WSS</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4.</PubMed_Title>
      <Author>Kadono, S., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.F(2005)61:169-173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16510984?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble tissue factor</PDB_Title>
      <PDB_ID>3ELA</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3ELA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity</PubMed_Title>
      <Author>Bjelke, J.R., et al.</Author>
      <Journal>J.Biol.Chem.(2008)283:25863-25870</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18640965?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR</PDB_Title>
      <PDB_ID>1TFH</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TFH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.5G9 complex.</PubMed_Title>
      <Author>Huang, M., et al.</Author>
      <Journal>J.Mol.Biol.(1998)275:873-894</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9480775?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine</PDB_Title>
      <PDB_ID>2ZZU</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZZU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design and synthesis of peptidomimetic factor VIIa inhibitors</PubMed_Title>
      <Author>Shiraishi, T., et al.</Author>
      <Journal>Chem.Pharm.Bull.(2010)58:38-44</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20045964?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>2HFT</PDB_ID>
      <Resolution>1.69</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HFT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution.</PubMed_Title>
      <Author>Muller, Y.A., et al.</Author>
      <Journal>J.Mol.Biol.(1996)256:144-159</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8609606?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid</PDB_Title>
      <PDB_ID>2AEI</PDB_ID>
      <Resolution>2.52</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2AEI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.</PubMed_Title>
      <Author>Kohrt, J.T., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2005)15:4752-4756</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16125385?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine</PDB_Title>
      <PDB_ID>1WUN</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WUN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor</PubMed_Title>
      <Author>Kadono, S., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2005)327:589-596</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15629154?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine</PDB_Title>
      <PDB_ID>2ZP0</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZP0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Peptide Mimetic Factor VIIa Inhibitor: Importance of Hydrophilic Pocket in S2 Site to Improve Selectivity aganist Thrombin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Discovery of Novel Heterocyclic Factor VIIa Inhibitors</PDB_Title>
      <PDB_ID>2F9B</PDB_ID>
      <Resolution>2.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2F9B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of novel heterocyclic factor VIIa inhibitors.</PubMed_Title>
      <Author>Rai, R., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:2270-2273</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16460932?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in the Presence of Ca2+, Mg2+, Na+, and Zn2+</PDB_Title>
      <PDB_ID>2A2Q</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A2Q</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.</PubMed_Title>
      <Author>Bajaj, S.P., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:24873-24888</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16757484?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue factor</PDB_Title>
      <PDB_ID>2PUQ</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PUQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Engineering the substrate and inhibitor specificities of human coagulation Factor VIIa</PubMed_Title>
      <Author>Larsen, K.S., et al.</Author>
      <Journal>Biochem.J.(2007)405:429-438</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17456045?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex.</PDB_Title>
      <PDB_ID>2AER</PDB_ID>
      <Resolution>1.87</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2AER</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High Resolution Structures of p-Aminobenzamidine- and Benzamidine-VIIa/Soluble Tissue Factor: Unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in factor VIIa</PubMed_Title>
      <Author>Bajaj, S.P., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:24873-24888</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16757484?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TF7A_3771 COMPLEX</PDB_Title>
      <PDB_ID>1W0Y</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1W0Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Design of Selective Phenylglycine Amide Tissue Factor/Factor Viia Inhibitors</PubMed_Title>
      <Author>Groebke-Zbinden, K., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2005)15:817</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15664864?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine</PDB_Title>
      <PDB_ID>1WTG</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WTG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor</PubMed_Title>
      <Author>Kadono, S., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2005)326:859-865</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15607748?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine</PDB_Title>
      <PDB_ID>1WQV</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WQV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor</PubMed_Title>
      <Author>Kadono, S., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2004)324:1227-1233</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15504346?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR</PDB_Title>
      <PDB_ID>1BOY</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BOY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the extracellular region of human tissue factor.</PubMed_Title>
      <Author>Harlos, K., et al.</Author>
      <Journal>Nature(1994)370:662-666</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8065454?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PHOSPHORYLATION OF THE CYTOPLASMIC TAIL OF TISSUE FACTOR AND ITS ROLE IN MODULATING STRUCTURE AND BINDING AFFINITY</PDB_Title>
      <PDB_ID>2CEH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CEH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and Binding Affinity</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121</PDB_Title>
      <PDB_ID>2C4F</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2C4F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Discovery of Fluoropyridine-Based Inhibitors of the Factor Viia/Tf Complex--Part 2</PubMed_Title>
      <Author>Kohrt, J.T., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:1060</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16289811?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex</PDB_Title>
      <PDB_ID>2B8O</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2B8O</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of Factor VIIa/soluble Tissue Factor complexed with Glu-Gly-Arg-Chloromethyl ketone</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor</PDB_Title>
      <PDB_ID>1UJ3</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1UJ3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor.</PubMed_Title>
      <Author>Ohto, U., et al.</Author>
      <Journal>J.Synchrotron Radiat.(2004)11:105-108</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14646147?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor</PDB_Title>
      <PDB_ID>2FLB</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FLB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Discovery of novel hydroxy pyrazole based factor IXa inhibitor.</PubMed_Title>
      <Author>Vijaykumar, D., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:2796-2799</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16487703?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of tissue factor-factor VIIa complex</PDB_Title>
      <PDB_ID>1J9C</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1J9C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Ligand Induced Conformational Transitions of Tissue Factor. Crystal Structure of the Tissue Factor:Factor VIIa Complex.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607</PDB_Title>
      <PDB_ID>2EC9</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EC9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor</PDB_Title>
      <PDB_ID>1Z6J</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Z6J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIa.</PubMed_Title>
      <Author>Schweitzer, B.A., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2005)15:3006-3011</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15913999?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Novel 5-Azaindole Factor VIIa Inhibitors</PDB_Title>
      <PDB_ID>2FLR</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2FLR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Novel 5-azaindole factor VIIa inhibitors.</PubMed_Title>
      <Author>Riggs, J.R., et al.</Author>
      <Journal>Bioorg.Med.Chem.Lett.(2006)16:3197-3200</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16621549?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PHOSPHORYLATION OF THE CYTOPLASMIC TAIL OF TISSUE FACTOR AND ITS ROLE IN MODULATING STRUCTURE AND BINDING AFFINITY</PDB_Title>
      <PDB_ID>2CFJ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2CFJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and Binding Affinity</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)</PDB_Title>
      <PDB_ID>1AHW</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AHW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.5G9 complex.</PubMed_Title>
      <Author>Huang, M., et al.</Author>
      <Journal>J.Mol.Biol.(1998)275:873-894</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9480775?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine</PDB_Title>
      <PDB_ID>1WV7</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WV7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor</PubMed_Title>
      <Author>Kadono, S., et al.</Author>
      <Journal>Biochem.Biophys.Res.Commun.(2005)327:589-596</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15629154?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.b.d.b.b.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1ahw</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Allosteric disulfide bond</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>